GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Creative Edge Nutrition FITX · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2012

Revenue

$3.8m

FY2012FY2012

Net income

$810,900

FY2012FY2012

Free cash flow

−$168,000

FY2012FY2012

Shareholders' equity

$2.0m

FY2012FY2012

Income statement

Fiscal years

FY2012
Revenue$3.8m
Gross profit$906,700
Operating income−$1.3m
Net income$810,900
Diluted earnings per share0.00

Balance sheet

At each fiscal year end

FY2012
Total assets$3.3m
Cash and short-term investments$268,600
Total liabilities$1.3m
Debt$237,900
Shareholders' equity$2.0m
Shares outstanding499m

Cash flow

Fiscal years

FY2012
Cash from operations−$137,400
Capital spending−$30,600
Free cash flow−$168,000

Latest quarters

By quarter end

Jun 2013Mar 2013Dec 2012Sept 2012Jun 2012Mar 2012Dec 2011Mar 2011
Revenue$646,600$524,700$774,600$2.3m$1.5m$1.6m——
Gross profit$111,500$195,800$49,800−$6,000$912,700———
Operating income−$1.2m−$465,800−$426,900−$1.4m$136,600−$680,000−$50,000−$50,000
Net income−$1.2m−$1.1m−$652,200$837,700$88,900$1.5m−$50,000−$50,000
Diluted earnings per share-0.00-0.00-0.000.000.00———
Total assets$2.9m$2.9m$2.8m$3.3m$3.6m———
Cash and short-term investments$41,800$80,800$95,000$268,600$217,300———
Debt$142,000$312,900$237,900$237,900$200,000$10,000——
Shareholders' equity$641,800$1.2m$1.8m$2.0m$2.7m−$390,000——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue220.2%59.7%—
Operating income132.2%——
Net income—73.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.2%———
Operating margin-18.1%———
Net margin7.2%———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%300%500%300%4915100%498193%3711%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1.2-for-1 split · 2 Apr 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.